close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

121.93 +2.18 (+1.82%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,083,323
Open 120.76
Bid (Size) 121.56 (100)
Ask (Size) 122.50 (100)
Prev. Close 119.75
Today's Range 120.44 - 122.66
52wk Range 73.31 - 122.43
Shares Outstanding 2,531,374,696
Dividend Yield 2.79%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology
In a move that underscores the pharmaceutical industry’s aggressive pivot toward integrated artificial intelligence, AstraZeneca (NASDAQ: AZN) recently announced the full acquisition of Modella AI, a... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Fiscal Brinkmanship: Data Blackout and the DHS Cliff Loom Over Markets After Narrow Funding Deal
In a week defined by high-stakes political theater and a brief but disruptive lapse in federal operations, Washington has managed to pull back from the edge of a total collapse—though only partially.... 
Via MarketMinute
Topics Economy Government Immigration

Performance

YTD
+14.5%
+14.5%
1 Month
+12.0%
+12.0%
3 Month
+42.1%
+42.1%
6 Month
+51.7%
+51.7%
1 Year
+36.0%
+36.0%

More News

Read More
Merck & Co. Inc. (NYSE:MRK) Beats Q4 Estimates but 2026 Outlook Cautions Investors ↗
Via Chartmill
Technical Breakout Setup for Merck & Co. Inc. (NYSE:MRK) ↗
Via Chartmill
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
Via Finterra
Topics Economy Government Intellectual Property
News headline image
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗
Via Stocktwits
Topics Economy Government World Trade
News headline image
USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border
Via MarketMinute
Topics Death Economy
AI Panic Hits Software, PayPal Faceplants, Walmart Joins the $1T Club ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
How Merck Is Preparing For The Patent Cliff Of Its Blockbuster Cancer Drug Keytruda ↗
Via Stocktwits
Topics Earnings Intellectual Property
News headline image
MRK Q4 Deep Dive: Pipeline Expansion and New Product Launches Shape Guidance
Via StockStory
News headline image
Merck (MRK) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Merck’s (NYSE:MRK) Q4 CY2025 Sales Beat Estimates
Via StockStory
Topics Earnings
News headline image
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline
From Merck & Co., Inc.
Via Business Wire
News headline image
The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs
Via MarketMinute
Topics Economy Government Intellectual Property
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
Merck (MRK) Q4 Earnings Report Preview: What To Look For
Via StockStory
Topics Artificial Intelligence
News headline image
Should You Buy Guardant Health Before Feb. 19? ↗
Via The Motley Fool
Topics Earnings
News headline image
2 Cash-Producing Stocks to Target This Week and 1 We Ignore
Via StockStory
News headline image
This Stock Is Already Up 58% This Year. Is It a Buy? ↗
Via The Motley Fool
News headline image
Constitutional Cliffhanger: Supreme Court Set to Rule on Executive Tariff Power as Market Braces for Margin Volatility
Via MarketMinute
Topics Economy Government World Trade
News headline image
The $4 Billion Avatar: How Synthesia is Defining the Era of Agentic Enterprise Media
Via TokenRing AI
Topics Artificial Intelligence
News headline image
FDA Codifies AI’s Role in Drug Production: New 2026 Guidelines Set Global Standard for Pharma Safety and Efficiency
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
Merck Announces Second-Quarter 2026 Dividend
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Pharmaceutical Stocks Set to Rebound in 2026 ↗
Via The Motley Fool

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 121.93
When was Merck & Co last traded?
The last trade of Merck & Co was at 02/06/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 308.65B
How many shares of Merck & Co are outstanding?
Merck & Co has 309B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today